SARS-CoV2 in a population over 75 years old:differences with young people

Background and Aim of the study: As of 17 June 2020, Italy had237 828 cases of SARS-CoV-2 infections, with about 35 000deaths;median age of cases 61 years, median age of deceased81 years A single-center observational cohort study was conducted to evaluate clinical features, laboratory characteristicscomparing two groups of subjects by age (>75 and 75 years and 75 years (37 3% vs 0 9%)compared to young people No difference was observed in thelength of stay (21 days on average), while the younger subjectswere treated with hydroxychloroquine more than the elderly(83 6% vs 40 6% respectively) as well as with lopinavir / ritonavir(39 4% vs 14 5%) Conclusions: Our data, although referring to a small sample ofsubjects, show that patients over 75 years of age are more fragile(die more), have better comorbidities and have been under treatedcompared to younger subjects